Inventor profile of:

Phillip M. SCHWARTZ

City:

Jerusalem

Country:

Israel

Published Applications:

15

Last publication date:

2026-05-07

Top Assignees for applications by Phillip M. SCHWARTZ

The entities that hold a legal rights for patent applications filed by inventor SCHWARTZ Phillip M.:

Recent patent applications by SCHWARTZ Phillip M.

Phillip M. SCHWARTZ from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07
US20260124281A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE

#2 | 2025-06-12
US20250186559A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE

#3 | 2025-06-12
US20250186558A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#4 | 2025-06-12
US20250186555A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-2

#5 | 2025-06-12
US20250186554A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1 AND ANALOGS THEREOF

#6 | 2024-12-19
US20240415936A1
Human necessities

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#7 | 2024-12-05
US20240398904A1
Human necessities

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#8 | 2024-06-06
US20240181020A1
Human necessities

TREATMENT OF HYPOPARATHYROIDISM

#9 | 2020-05-07
US20200138913A1
Human necessities

Formulations for oral administration of active agents

#10 | 2019-07-11
US20190209657A1
Human necessities

Formulations for oral administration of active agents

#11 | 2018-02-22
US20180050096A1
Human necessities

TREATMENT OF HYPOPARATHYROIDISM

#12 | 2018-02-08
US20180036382A1
Human necessities

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE

#13 | 2018-02-08
US20180036234A1
Human necessities

TREATMENT OF BONE FRACTURES AND DEFECTS

#14 | 2018-02-01
US20180028622A1
Human necessities

TREATMENT OF OSTEOPOROSIS

#15 | 2018-01-25
US20180021272A1
Human necessities

Formulations for oral administration of active agents

InventorID:

2102896 ⎘